Fourth, although our study revealed a substantial beneficial association between RSs use and a decreased CRP level among RA patients, it must be recognized that participants were not initially randomly categorized into users and nonusers and were recruited from a single country only. This evidence concerns the gene CRP and rheumatoid arthritis.